Twist Bioscience 8-K

Deal pendingContract / partnershipEquity raise

Invenra license and technology transfer deal pairs cash and stock payments with an equity stake and the right to designate a director.

Filed 2026-02-17 07:09 ET

Summary

Private stock issuance and investment in Invenra. Twist agreed to issue up to 632,328 shares and pay cash in connection with an Invenra license and technology transfer, and to acquire an approximately 6% ownership position in Invenra through shares issued to two Invenra investors.

Key Figures

  • Up to 324,558 Twist shares plus $5M cash to Invenra for a license agreement and technology transfer.
  • Up to 307,770 Twist shares to two Invenra investors in exchange for Invenra preferred stock representing an approximately 6% ownership position.
  • Twist may designate one Invenra director; the Invenra board members, including Twist’s designee, may approve two additional directors.
  • Twist is filing a prospectus supplement to register resale of the shares.

Investor Takeaways

  • Watch for issuance and registered resales of the shares, which may affect Twist’s share count and trading supply.

The summary is written by an AI model reading the filing.

Model 005 · prompt 01d34d48e3

Feedback